1 Gurtner, GC, Werner, S, Barrandon, Y, et al. (2008) Wound repair and regeneration. Nature 453, 314–321.
2 Cruse, JM & Wang, H (2002) Cellular and molecular alterations in spinal cord injury patients with pressure ulcers: a preliminary report. Exp Mol Pathol 72, 124–131.
3 Hulsey, TK, O'Neill, JA, Neblett, WR, et al. (1980) Experimental wound healing in essential fatty acid deficiency. J Pediatr Surg 15, 505–508.
4 Bjerve, KS (1989) n-3 Fatty acid deficiency in man. J Intern Med Suppl 731, 171–175.
5 Theilla, M, Singer, P, Cohen, J, et al. (2007) A diet enriched in eicosapentanoic acid, gamma-linolenic acid and antioxidants in the prevention of new pressure ulcer formation in critically ill patients with acute lung injury: a randomized, prospective, controlled study. Clin Nutr 26, 752–757.
6 European Pressure Ulcer Advisory Panel (2010) .
7 Knaus, WA, Draper, EA, Wagner, DP, et al. (1985) APACHE II: a severity of disease classification system. Crit Care Med 13, 818–829.
8 Haisjackl, M, Hasibeder, W, Klaunzer, S, et al. (1990) Diminished reactive hyperemia in the skin of critically ill patients. Crit Care Med 18, 813–818.
9 George-Saintilus, E, Tommasulo, B, Cal, CE, et al. (2009) Pressure ulcer PUSH score and traditional nursing assessment in nursing home residents: do they correlate? J Am Med Dir Assoc 10, 141–144.
10 Thomas, DR, Rodeheaver, GT, Bartolucci, AA, et al. (1997) Pressure ulcer scale for healing: derivation and validation of the PUSH tool. Adv Wound Care 10, 96–101.
11 Shahin, ES, Dassen, T & Halfens, RJ (2008) Pressure ulcer prevalence and incidence in intensive care patients: a literature review. Nurs Crit Care 13, 71–79.
12 Terekeci, H, Kucukardali, Y, Top, C, et al. (2008) Risk assessment of study of the pressure ulcers in intensive care unit patients. Eur J Int Med 20, 394–397.
13 Kuijpers, TW, van Lier, RA, Hamann, D, et al. (1997) LAD1/variant. A novel immunodefiency syndrome characterized by dysfunctional beta2 integrins. J Clin Invest 100, 1725–1733.
14 Hughes, DA, Pinder, AC, Piper, Z, et al. (1996) Fish oil supplementation inhibits the expression of major histocompatibility complex class II molecules and adhesion molecules on human monocytes. Am J Clin Nutr 63, 267–272.
15 Mayer, K, Merfels, M, Muhly-Reinholz, M, et al. (2002) Omega-3 fatty acids suppress monocyte adhesion to human endothelial cells: role of endothelial PAF generation. Am J Physiol Heart Circ Physiol 283, 811–818.
16 Schaefer, MB, Ott, J, Mohr, A, et al. (2007) Immunomodulation by n-3- versus n-6-rich lipid emulsions in murine acute lung injury – role of platelet-activating factor receptor. Crit Care Med 35, 544–554.
17 Fukuda, S & Schmid-Schonbein, GW (2003) Regulation of CD18 expression on neutrophils in response to fluid shear stress. Proc Natl Acad Sci U S A 100, 13152–13157.
18 Evans, BJ, McDowall, A, Taylor, PC, et al. (2006) Shedding of lymphocyte function-associated antigen-1 (LFA-1) in a human inflammatory response. Blood 107, 3593–3599.
19 Kaufman, J, Graf, BA, Leung, EC, et al. (2001) Fibroblasts as sentinel cells: role of the CD40–CD40 ligand system in fibroblast activation and lung inflammation and fibrosis. Chest 120, S53–S55.
20 Sanderson, P & Calder, PC (1998) Dietary fish oil diminishes lymphocyte adhesion to macrophage and endothelial cell monolayers. Immunology 94, 79–87.
21 Mayer, K, Meyer, S, Reinholz-Muhly, M, et al. (2003) Short-time infusion of fish oil-based lipid emulsions, approved for parenteral nutrition, reduces monocyte proinflammatory cytokine generation and adhesive interaction with endothelium in humans. J Immunol 171, 4837–4843.
22 Albina, JE, Gladden, P, Walsh, WR, et al. (1993) Detrimental effects of an omega-3 fatty acid-enriched diet on wound healing. JPEN J Parenter Enteral Nutr 17, 519–521.
23 Chiu, WC, Wang, YC, Chien, YW, et al. (2009) Effects of dietary fish oil supplementation on cellular adhesion molecule expression and tissue myeloperoxidase activity in hypercholesterolemic mice with sepsis. J Nutr Biochem 20, 254–260.
24 Bates, EJ, Ferrante, A, Harvey, DP, et al. (1993) Polyunsaturated fatty acids increase neutrophil adherence and integrin receptor expression. J Leukoc Biol 53, 420–426.
25 Schwab, JM, Chiang, N, Arita, M, et al. (2007) Resolvin E1 and protectin D1 activate inflammation–resolution programmes. Nature 447, 869–874.
26 Brooks, JD, Milne, GL, Yin, H, et al. (2008) Formation of highly reactive cyclopentenone isoprostane compounds (A3/J3-isoprostanes) in vivo from eicosapentaenoic acid. J Biol Chem 283, 12043–12055.
27 Spite, M, Norling, LV, Summers, L, et al. (2009) Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature 461, 1287–1291.
28 Mancuso, P, Whelan, J, DeMichele, SJ, et al. (1997) Effects of eicosapentaenoic and gamma-linolenic acid on lung permeability and alveolar macrophage eicosanoid synthesis in endotoxic rats. Crit Care Med 25, 523–532.
29 Singer, P, Theilla, M, Fisher, H, et al. (2006) Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med 34, 1033–1038.